Skip to main content

Table 2 Assessment of morphological remission and maintenance of complete remission (CR)

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

BM blasts count No %
Assessment of early response to chemotherapy 40  
 Blasts% day 28
  ≤ 5% 16 40
  > 5% 23 57.5
  Died 1 2.5
Assessment of maintenance of CR
 Blasts% 2 m
  ≤ 5% 26/36 72.2
  > 5% 8/36 22.2
  Died 2/36 5.5
 Blasts% 4 m
  ≤ 5% 22/29 75.9
  > 5% 7/29 24.1
 Blasts% 6 m
  ≤ 5% 20/29 68.9
  > 5% 9/29 31.1